TIOCONAZOLE

TIOCONAZOLE was reported 1541 times

These side effects are most commonly reported by patients taking TIOCONAZOLE:

# Side effect Count
0 VULVOVAGINAL BURNING SENSATION 526
1 DRUG INEFFECTIVE 441
2 VULVOVAGINAL SWELLING 295
3 VULVOVAGINAL PAIN 229
4 CONDITION AGGRAVATED 226
5 VULVOVAGINAL PRURITUS 197
6 VULVOVAGINAL DISCOMFORT 161
7 VAGINAL DISCHARGE 59
8 UNDERDOSE 54
9 VAGINAL HAEMORRHAGE 54
10 HYPERSENSITIVITY 53
11 VULVOVAGINAL ERYTHEMA 52
12 OFF LABEL USE 36
13 CHEMICAL BURN OF GENITALIA 29
14 HEADACHE 24
15 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22
16 EXPIRED PRODUCT ADMINISTERED 21
17 NAUSEA 20
18 SWELLING 20
19 DIZZINESS 19
20 DYSURIA 19
21 FATIGUE 19
22 ARTHRALGIA 18
23 DRUG HYPERSENSITIVITY 18
24 PAIN 18
25 VOMITING 18
26 ABDOMINAL DISCOMFORT 17
27 ABDOMINAL PAIN 17
28 DECREASED APPETITE 17
29 INTENTIONAL PRODUCT USE ISSUE 17
30 PRODUCT USE IN UNAPPROVED INDICATION 17
31 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17
32 INFUSION RELATED REACTION 16
33 ADVERSE DRUG REACTION 15
34 ALOPECIA 15
35 BLOOD CHOLESTEROL INCREASED 15
36 C-REACTIVE PROTEIN INCREASED 15
37 DRUG INTOLERANCE 15
38 FIBROMYALGIA 15
39 GENERAL PHYSICAL HEALTH DETERIORATION 15
40 HELICOBACTER INFECTION 15
41 HEPATIC ENZYME INCREASED 15
42 HYPERCHOLESTEROLAEMIA 15
43 HYPERTENSION 15
44 HYPOAESTHESIA 15
45 MOBILITY DECREASED 15
46 OSTEOARTHRITIS 15
47 TYPE 2 DIABETES MELLITUS 15
48 VULVOVAGINAL INFLAMMATION 15
49 RASH 14
50 URTICARIA 14
51 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13
52 ABDOMINAL PAIN UPPER 12
53 CHEMICAL BURN 10
54 DRUG EFFECT LESS THAN EXPECTED 10
55 VAGINAL ODOUR 10
56 DRUG EFFECT INCOMPLETE 9
57 MATERNAL EXPOSURE DURING PREGNANCY 9
58 PRURITUS 9
59 VULVOVAGINAL INJURY 9
60 VULVOVAGINAL RASH 9
61 ADVERSE EVENT 8
62 CHEST PAIN 8
63 GENITAL PARAESTHESIA 8
64 PNEUMONIA 8
65 PRODUCT ADMINISTRATION ERROR 8
66 VAGINAL MUCOSAL BLISTERING 8
67 VULVOVAGINAL EXFOLIATION 8
68 ABORTION SPONTANEOUS 7
69 APPLICATION SITE PAIN 7
70 CHILLS 7
71 DERMATITIS CONTACT 7
72 DYSPNOEA 7
73 MALAISE 7
74 PAIN IN EXTREMITY 7
75 VISUAL IMPAIRMENT 7
76 ARTHRITIS 6
77 BONE EROSION 6
78 CROHN^S DISEASE 6
79 EAR INFECTION 6
80 EXOSTOSIS 6
81 FOOT DEFORMITY 6
82 HEPATIC CIRRHOSIS 6
83 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
84 INSOMNIA 6
85 JOINT DISLOCATION 6
86 JOINT STIFFNESS 6
87 LARYNGITIS 6
88 LUPUS VULGARIS 6
89 LUPUS-LIKE SYNDROME 6
90 OEDEMA PERIPHERAL 6
91 OSTEOPOROSIS 6
92 PRESCRIBED OVERDOSE 6
93 PYREXIA 6
94 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6
95 URINARY TRACT INFECTION 6
96 VULVOVAGINAL DRYNESS 6
97 ANXIETY 5
98 BLISTER 5
99 BURNING SENSATION 5
100 DIARRHOEA 5
101 GENITAL BLISTER 5
102 RETINITIS 5
103 THERAPEUTIC PRODUCT EFFECT DELAYED 5
104 VAGINAL MYCOSIS 5
105 APPLICATION SITE SWELLING 4
106 DEVICE FAILURE 4
107 EXPOSURE DURING PREGNANCY 4
108 FOREIGN BODY 4
109 FOREIGN BODY IN REPRODUCTIVE TRACT 4
110 FUNGAL INFECTION 4
111 GAIT DISTURBANCE 4
112 INTENTIONAL PRODUCT MISUSE 4
113 MEDICAL DEVICE DISCOMFORT 4
114 SLEEP DISORDER 4
115 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4
116 THERAPY NON-RESPONDER 4
117 UPPER RESPIRATORY TRACT INFECTION 4
118 VAGINAL SWELLING 4
119 WEIGHT DECREASED 4
120 ABDOMINAL DISTENSION 3
121 ACCIDENTAL EXPOSURE TO PRODUCT 3
122 AMNESIA 3
123 APPLICATION SITE ERYTHEMA 3
124 BACK PAIN 3
125 CONSTIPATION 3
126 DISCOMFORT 3
127 DRUG EXPOSURE DURING PREGNANCY 3
128 EXTRA DOSE ADMINISTERED 3
129 EYE SWELLING 3
130 FEBRILE NEUTROPENIA 3
131 GAIT INABILITY 3
132 INJURY 3
133 JOINT SWELLING 3
134 LIVER FUNCTION TEST INCREASED 3
135 LIVER INJURY 3
136 MUSCLE SPASMS 3
137 MUSCULOSKELETAL STIFFNESS 3
138 PERIPHERAL SWELLING 3
139 SINUSITIS 3
140 SKIN DISORDER 3
141 SKIN EXFOLIATION 3
142 VAGINAL EXFOLIATION 3
143 VAGINAL INFECTION 3
144 VIRAL UPPER RESPIRATORY TRACT INFECTION 3
145 WEIGHT INCREASED 3
146 WOUND 3
147 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2
148 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2
149 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2
150 APPLICATION SITE EXFOLIATION 2
151 APPLICATION SITE HAEMORRHAGE 2
152 APPLICATION SITE RASH 2
153 APPLICATION SITE WARMTH 2
154 ARTHROPATHY 2
155 ASTHENIA 2
156 ASTHMA 2
157 AUTOIMMUNE DISORDER 2
158 BREAST CANCER STAGE I 2
159 BRONCHITIS 2
160 CHEMICAL INJURY 2
161 CONFUSIONAL STATE 2
162 CONTUSION 2
163 COVID-19 2
164 DEATH 2
165 DEEP VEIN THROMBOSIS POSTOPERATIVE 2
166 DELIRIUM 2
167 DEPRESSION 2
168 DERMATITIS ALLERGIC 2
169 DISABILITY 2
170 DISLOCATION OF VERTEBRA 2
171 DRUG ADMINISTRATION ERROR 2
172 DRUG EFFECT DECREASED 2
173 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
174 DRUG INTERACTION 2
175 DUODENAL ULCER PERFORATION 2
176 DYSGEUSIA 2
177 DYSPAREUNIA 2
178 DYSPHAGIA 2
179 FEELING HOT 2
180 FLATULENCE 2
181 FOLLICULITIS 2
182 GENITAL PAIN 2
183 GLOSSODYNIA 2
184 GRIP STRENGTH DECREASED 2
185 HAND DEFORMITY 2
186 HIP ARTHROPLASTY 2
187 HYPERHIDROSIS 2
188 IMPAIRED HEALING 2
189 INCORRECT PRODUCT ADMINISTRATION DURATION 2
190 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2
191 INFECTION 2
192 INFLAMMATION 2
193 INFLUENZA LIKE ILLNESS 2
194 IRRITABLE BOWEL SYNDROME 2
195 JOINT RANGE OF MOTION DECREASED 2
196 KNEE ARTHROPLASTY 2
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
198 LOWER LIMB FRACTURE 2
199 MEMORY IMPAIRMENT 2
200 MIGRAINE 2
201 MUSCLE INJURY 2
202 MUSCULAR WEAKNESS 2
203 NASOPHARYNGITIS 2
204 OEDEMA 2
205 OEDEMA GENITAL 2
206 OROPHARYNGEAL PAIN 2
207 PALPITATIONS 2
208 PARVOVIRUS B19 INFECTION 2
209 PEMPHIGUS 2
210 PERICARDITIS 2
211 POLLAKIURIA 2
212 POLYMENORRHOEA 2
213 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
214 PRODUCT DOSE OMISSION ISSUE 2
215 PSORIASIS 2
216 PSORIATIC ARTHROPATHY 2
217 PULMONARY FIBROSIS 2
218 RASH GENERALISED 2
219 RHEUMATIC FEVER 2
220 RHEUMATOID ARTHRITIS 2
221 RHEUMATOID FACTOR POSITIVE 2
222 ROAD TRAFFIC ACCIDENT 2
223 SCIATICA 2
224 SERONEGATIVE ARTHRITIS 2
225 SKIN DISCOLOURATION 2
226 SKIN FISSURES 2
227 SWOLLEN JOINT COUNT INCREASED 2
228 SYNCOPE 2
229 SYNOVITIS 2
230 SYSTEMIC LUPUS ERYTHEMATOSUS 2
231 TACHYCARDIA 2
232 TENDERNESS 2
233 THERAPEUTIC PRODUCT EFFECT DECREASED 2
234 VAGINAL EROSION 2
235 VAGINAL INFLAMMATION 2
236 VULVOVAGINAL ULCERATION 2
237 WALKING AID USER 2
238 WHEEZING 2
239 WOUND INFECTION 2
240 ABDOMINAL PAIN LOWER 1
241 ABNORMAL FAECES 1
242 ACNE 1
243 ACUTE RESPIRATORY FAILURE 1
244 ADMINISTRATION SITE PARAESTHESIA 1
245 ADVERSE REACTION 1
246 AFFECT LABILITY 1
247 ALANINE AMINOTRANSFERASE INCREASED 1
248 ALLERGIC REACTION TO EXCIPIENT 1
249 ALLERGY TO ANIMAL 1
250 AMYLASE INCREASED 1
251 ANAEMIA 1
252 ANAPHYLACTIC REACTION 1
253 ANORECTAL DISCOMFORT 1
254 APPLICATION SITE BURN 1
255 APPLICATION SITE PAPULES 1
256 APPLICATION SITE PUSTULES 1
257 APPLICATION SITE REACTION 1
258 APPLICATION SITE SCAB 1
259 APPLICATION SITE VESICLES 1
260 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
261 BACTERIAL INFECTION 1
262 BACTERIAL VAGINOSIS 1
263 BACTERIAL VULVOVAGINITIS 1
264 BARRETT^S OESOPHAGUS 1
265 BLOOD CREATINE INCREASED 1
266 BLOOD GLUCAGON ABNORMAL 1
267 BLOOD LOSS ANAEMIA 1
268 BLOOD PRESSURE ABNORMAL 1
269 BLOOD PRESSURE INCREASED 1
270 BLOOD URINE PRESENT 1
271 BODY HEIGHT DECREASED 1
272 BRAIN CONTUSION 1
273 BREAST PAIN 1
274 BREAST TENDERNESS 1
275 BURNS SECOND DEGREE 1
276 CELLULITIS 1
277 CEREBRAL HAEMORRHAGE 1
278 CEREBRAL INFARCTION 1
279 CEREBROVASCULAR ACCIDENT 1
280 CHANGE OF BOWEL HABIT 1
281 CHEMICAL BURN OF SKIN 1
282 CHROMATURIA 1
283 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1
284 CLEFT LIP 1
285 COGNITIVE DISORDER 1
286 CONCUSSION 1
287 CONGENITAL ANOMALY 1
288 CONTRAINDICATED PRODUCT ADMINISTERED 1
289 CRANIOSYNOSTOSIS 1
290 CRYING 1
291 DEVICE USE ISSUE 1
292 DIABETES MELLITUS INADEQUATE CONTROL 1
293 DRUG DEPENDENCE 1
294 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
295 DRY MOUTH 1
296 DRY SKIN 1
297 DYSPEPSIA 1
298 EATING DISORDER 1
299 ENLARGED CLITORIS 1
300 ERYTHEMA 1
301 ERYTHEMA INFECTIOSUM 1
302 EXPOSURE VIA BREAST MILK 1
303 EXPOSURE VIA SKIN CONTACT 1
304 EYE INFECTION 1
305 EYE IRRITATION 1
306 FACE OEDEMA 1
307 FALL 1
308 FEELING ABNORMAL 1
309 FEELING OF BODY TEMPERATURE CHANGE 1
310 FLUID INTAKE REDUCED 1
311 FOURNIER^S GANGRENE 1
312 GASTROINTESTINAL HAEMORRHAGE 1
313 GASTROINTESTINAL TELANGIECTASIA 1
314 GENITAL DISCOLOURATION 1
315 GENITAL HYPOAESTHESIA 1
316 GENITAL INJURY 1
317 GENITAL ULCERATION 1
318 HAEMORRHAGIC OVARIAN CYST 1
319 HAEMORRHAGIC URTICARIA 1
320 HAEMORRHOIDS 1
321 HEREDITARY ANGIOEDEMA 1
322 HOSPITALISATION 1
323 HYDRONEPHROSIS 1
324 HYPERAEMIA 1
325 HYPERAESTHESIA 1
326 HYPOKALAEMIA 1
327 HYPONATRAEMIA 1
328 ILLNESS 1
329 IMPAIRED WORK ABILITY 1
330 INCORRECT DOSE ADMINISTERED 1
331 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
332 INFLUENZA A VIRUS TEST 1
333 INFUSION SITE BRUISING 1
334 INFUSION SITE DISCHARGE 1
335 INFUSION SITE HAEMORRHAGE 1
336 INFUSION SITE PAIN 1
337 INITIAL INSOMNIA 1
338 INJECTION SITE ERYTHEMA 1
339 INJECTION SITE PAIN 1
340 INJECTION SITE PRURITUS 1
341 INJECTION SITE SWELLING 1
342 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1
343 LABIA ENLARGED 1
344 LETHARGY 1
345 LIMB INJURY 1
346 LIP SWELLING 1
347 LOSS OF CONSCIOUSNESS 1
348 LYMPHADENITIS 1
349 LYMPHATIC DISORDER 1
350 MAST CELL ACTIVATION SYNDROME 1
351 MATERNAL DRUGS AFFECTING FOETUS 1
352 MATERNAL EXPOSURE DURING BREAST FEEDING 1
353 METRORRHAGIA 1
354 MICTURITION URGENCY 1
355 MIDDLE INSOMNIA 1
356 MULTIPLE ALLERGIES 1
357 MYALGIA 1
358 NAIL DISORDER 1
359 NECROTISING FASCIITIS 1
360 NEUTROPHIL COUNT INCREASED 1
361 NO ADVERSE EVENT 1
362 NO THERAPEUTIC RESPONSE 1
363 NODULE 1
364 OBSTRUCTION 1
365 OSTEONECROSIS OF JAW 1
366 PANCREATITIS 1
367 PANIC ATTACK 1
368 PARAESTHESIA 1
369 PELVIC PAIN 1
370 PHLEBITIS 1
371 PLATELET COUNT INCREASED 1
372 POOR QUALITY SLEEP 1
373 POST PROCEDURAL INFECTION 1
374 PRESCRIBED UNDERDOSE 1
375 PRESYNCOPE 1
376 PRODUCT COMPLAINT 1
377 PRODUCT DISTRIBUTION ISSUE 1
378 PRODUCT PACKAGING ISSUE 1
379 PRODUCT PHYSICAL ISSUE 1
380 PRODUCT QUALITY ISSUE 1
381 PRODUCT RESIDUE PRESENT 1
382 PRODUCT SUBSTITUTION ISSUE 1
383 PRODUCT USE COMPLAINT 1
384 PRODUCT USE ISSUE 1
385 PRURITUS GENERALISED 1
386 RASH MACULAR 1
387 REDUCED BLADDER CAPACITY 1
388 RENAL FAILURE 1
389 RENAL IMPAIRMENT 1
390 RESTLESS LEGS SYNDROME 1
391 ROSACEA 1
392 ROTATOR CUFF SYNDROME 1
393 RUBBER SENSITIVITY 1
394 SEASONAL ALLERGY 1
395 SECOND DEGREE CHEMICAL BURN OF SKIN 1
396 SEPTIC SHOCK 1
397 SHOCK 1
398 SKIN INDENTATION 1
399 SKIN IRRITATION 1
400 SKIN LACERATION 1
401 SKIN REACTION 1
402 SKIN ULCER HAEMORRHAGE 1
403 SOMNOLENCE 1
404 SPINAL COMPRESSION FRACTURE 1
405 STOMA COMPLICATION 1
406 THERAPEUTIC RESPONSE DECREASED 1
407 THERAPY CESSATION 1
408 THROAT IRRITATION 1
409 THROAT TIGHTNESS 1
410 THROMBOSIS 1
411 TISSUE IRRITATION 1
412 TRANSIENT ISCHAEMIC ATTACK 1
413 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1
414 TREMOR 1
415 URINE OUTPUT INCREASED 1
416 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 1
417 VAGINAL LACERATION 1
418 VAGINAL ULCERATION 1
419 VAGINITIS 1
420 VIRAL INFECTION 1
421 VULVAL DISORDER 1
422 VULVAL ERYTHEMA 1
423 VULVAL OEDEMA 1
424 VULVOVAGINAL HYPOAESTHESIA 1
425 VULVOVAGINAL MYCOTIC INFECTION 1
426 VULVOVAGINITIS 1
427 WHITE BLOOD CELL COUNT INCREASED 1
428 WRONG DRUG ADMINISTERED 1
429 WRONG PRODUCT ADMINISTERED 1
430 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1